← Research library

Effects of neuroprotector cortexin on the dynamics of neuroendocrine system parameters in patients with organic emotionally labile (asthenic) disorders

Comparison in people · 2013

What was studied
Patients with organic emotionally labile/asthenic disorders
Main finding
Reports endocrine changes alongside clinical improvement when Cortexin was added to standard treatment.

Reported findings and study design

Population or model Patients with organic emotionally labile/asthenic disorders

Results · Primary indexed abstract, PMID 23667876.
MeasureResultComparison, timing and statistics
Neuroendocrine measuresCortisol, DHEA-sulphate and thyroid-hormone changes reported during adjunctive care

No numerical effect estimate or adequately documented allocation is available in the abstract. Hormone-marker changes are not a general recovery benefit.

Source for these results ↗ · Reviewed 2026-11-05

Study limitations and source details

Study limitations

  • Abstract-level record does not adequately describe allocation, blinding or sample size.
  • Hormone changes do not validate general stress resilience or healthy-person enhancement.

Source details

Indexed abstract and citation checked via Europe PMC / PubMed; full methods and risk of bias not appraised.

Sources checked

Citation

Human comparative studyEnglish abstract

Levchuk LA, Ivanova SA, Semke VY. Effects of neuroprotector cortexin on the dynamics of neuroendocrine system parameters in patients with organic emotionally labile (asthenic) disorders Bull Exp Biol Med 155(1):75-77. PMID 23667876

Study source ↗ · DOI 10.1007/s10517-013-2083-7 · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards